Correlation of CpG island methylator phenotype with poor prognosis in hepatocellular carcinoma

被引:26
|
作者
Cheng, Yue [1 ,2 ]
Zhang, Changsong [1 ,3 ]
Zhao, Jun [1 ]
Wang, Chenyang [1 ]
Xu, Yun [1 ]
Han, Zhipeng [1 ]
Jiang, Guocheng [1 ]
Guo, Xianling [1 ]
Li, Rong [1 ]
Bu, Xinxin [1 ]
Wu, Mengchao [1 ]
Wei, Lixin [1 ]
机构
[1] Second Mil Med Univ, Eastern Hepatobiliary Hosp, Tumor Immunol & Gene Therapy Ctr, Shanghai 200438, Peoples R China
[2] Hosp Heyuan City, Dept Clin Oncol, Heyuan City, Guangdong, Peoples R China
[3] Soochow Univ, Coll Med, Changzhou Tumor Hosp, Clin Oncol Lab, Suzhou, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
CIMP; Methylation; Hepatocellular carcinoma; Prognosis; DNA METHYLATION; PROMOTER HYPERMETHYLATION; HEPATIC RESECTION; EPIGENETIC EVENTS; MULTIPLE GENES; TUMOR; EXPRESSION; SURVIVAL; CANCER; LIVER;
D O I
10.1016/j.yexmp.2009.10.008
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
CpG island methylator phenotype (CIMP), in which multiple genes are concurrently methylated, is an important mechanism in hepatocellular carcinoma development. We determined a hypermethylation profile in hepatocellular carcinoma (HCC). We examined the promoter methylation status of 10 genes in 60 cases of hepatocellular carcinoma (HCC), 60 cases of paired non-tumor tissues, and 6 cases of normal tissues by methylation-specific PCR. The average methylated gene numbers were significantly different between HCC and nontumor tissues (p<0.001). We found metastasis, gamma-glutamyl transpeptidase (GGT) and tumor node metastasis (TNM) stage were significantly different among patients with different CIMP status. Patients with high frequency CIMP tumors had significantly worse survival than patients with intermediate frequency or no CIMP tumors (p<0.01 and p<0.05, respectively). Our results suggested that CIMP could serve as a molecular marker of late stage and poorly prognostic HCC development. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:112 / 117
页数:6
相关论文
共 50 条
  • [31] The CpG Island Methylator Phenotype: What's in a Name?
    Hughes, Laura A. E.
    Melotte, Veerle
    de Schrijver, Joachim
    de Maat, Michiel
    Smit, Vincent T. H. B. M.
    Bovee, Judith V. M. G.
    French, Pim J.
    van den Brandt, Piet A.
    Schouten, Leo J.
    de Meyer, Tim
    van Criekinge, Wim
    Ahuja, Nita
    Herman, James G.
    Weijenberg, Matty P.
    van Engeland, Manon
    CANCER RESEARCH, 2013, 73 (19) : 5858 - 5868
  • [32] The origin of colorectal cancer with CpG island methylator phenotype
    Toyota, Minoru
    Yamamoto, Eiichiro
    Suzuki, Hiromu
    Kamimae, Seiko
    Yamano, Hiro-o
    Shinomura, Yasuhisa
    Innai, Kohzoh
    CANCER RESEARCH, 2010, 70
  • [33] Prognostic value of CpG island methylator phenotype among hepatocellular carcinoma patients: A systematic review and meta-analysis
    Wang, Qian
    Wang, Gang
    Liu, Chaoxu
    He, Xianli
    INTERNATIONAL JOURNAL OF SURGERY, 2018, 54 : 92 - 99
  • [34] The CpG island methylator phenotype is closely associated with prognosis in patients with oral squamous cell carcinomas
    Abe, Masanobu
    Yamashita, Satoshi
    Ushijima, Toshikazu
    Hoshi, Kazuto
    CANCER RESEARCH, 2024, 84 (06)
  • [35] High CpG island methylator phenotype is associated with lymph node metastasis and prognosis in gastric cancer
    Chen, Hua-Yun
    Zhu, Bao-He
    Zhang, Chang-Hua
    Yang, Dong-Jie
    Peng, Jian-Jun
    Chen, Jian-Hui
    Liu, Fa-Keng
    He, Yu-Long
    CANCER SCIENCE, 2012, 103 (01): : 73 - 79
  • [36] Identification of a CpG-island methylator phenotype (CIMP) in a subgroup of pilocytic astrocytoma with favorable prognosis
    Witt, Hendrik
    Zapatka, Marc
    Jones, David W.
    Huriye, Cin
    Remke, Marc
    Janzarik, Wibke
    Gnekow, Astrid
    Witt, Olaf
    Lichter, Peter
    Korshunov, Andrey
    Pfister, Stefan M.
    CANCER RESEARCH, 2011, 71
  • [37] Tumors with unmethylated MLH1 and the CpG island methylator phenotype are associated with a poor prognosis in stage II colorectal cancer patients
    Fu, Tao
    Liu, Yanliang
    Li, Kai
    Wan, Weiwei
    Pappou, Emmanouil P.
    Iacobuzio-Donahue, Christine A.
    Kerner, Zachary
    Baylin, Stephen B.
    Wolfgang, Christopher L.
    Ahuja, Nita
    ONCOTARGET, 2016, 7 (52) : 86480 - 86489
  • [38] Prognostic value of CpG island methylator phenotype in gastric cancer
    Xiao, Huashi
    Fu, Jiaxin
    Abe, Masanobu
    Ji, Jiafu
    Zong, Liang
    CANCER SCIENCE, 2018, 109 (08): : 2623 - 2625
  • [39] The CpG Island Methylator Phenotype is A Potential Therapeutic Target in Osteosarcoma
    Asano, Naofumi
    Takeshima, Hideyuki
    Yamashita, Satoshi
    Takamatsu, Hironori
    Hattori, Naoko
    Kobayashi, Eisuke
    Nakayama, Robert
    Nakamura, Masaya
    Matsumoto, Morio
    Kawai, Akira
    Kondo, Tadashi
    Ushijima, Toshikazu
    CANCER SCIENCE, 2018, 109 : 1413 - 1413
  • [40] CpG Island Methylator Phenotype Predicts Progression of Malignant Melanoma
    Tanemura, Atsushi
    Terando, Alicia M.
    Sim, Myung-Shin
    van Hoesel, Anneke Q.
    de Maat, Michiel F. G.
    Morton, Donald L.
    Hoon, Dave S. B.
    CLINICAL CANCER RESEARCH, 2009, 15 (05) : 1801 - 1807